Vitamin B6 inhibits activity of Helicobacter pylori adenylosuccinate synthetase and growth of reference and clinical, antibiotic-resistant H. pylori strains
The current therapies against gastric pathogen Helicobacter pylori are ineffective in over 20% of patients. Enzymes belonging to the purine salvage pathway are considered as novel drug targets in this pathogen. Therefore, the main aim of the current study was to determine the antibacterial activity...
Saved in:
| Main Authors: | Marta Ilona Wojtyś, Weronika Maksymiuk, Marta Narczyk, Ante Bubić, Ivana Leščić Ašler, Paweł Krzyżek, Grażyna Gościniak, Elżbieta Katarzyna Jagusztyn-Krynicka, Agnieszka Bzowska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2024.2372734 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current insights in ultra-rare adenylosuccinate synthetase 1 myopathy – meeting report on the First Clinical and Scientific Conference. 3 June 2024, National Centre for Advancing Translational Science, Rockville, Maryland, the United States of America
by: Emma Rybalka, et al.
Published: (2024-11-01) -
N-acetylglutamate synthetase deficiency - literature review
by: Krystian Wdowiak, et al.
Published: (2025-01-01) -
Morphology of Helicobacter pylori as a result of peptidoglycan and cytoskeleton rearrangements
by: Paweł Krzyżek, et al.
Published: (2018-09-01) -
Helicobacter pylori and its effect on the body. Worldwide prevalence of Helicobacter pylori
by: I. Shukhtina, et al.
Published: (2016-06-01) -
Current prevalence of Helicobacter pylori infection in patients with dyspepsia treated in Warsaw, Poland
by: Tadeusz Tacikowski, et al.
Published: (2017-05-01)